Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	TPCN2 RYR1 ITPR2 ITPR3	1.93e-06	18	103	4	GO:0015278
GeneOntologyMolecularFunction	phosphatidylinositol binding	ANKFY1 TPCN2 INPPL1 KRIT1 IQGAP1 ITPR2 ITPR3 SNX25 GAB4 ZFYVE26	5.49e-06	316	103	10	GO:0035091
GeneOntologyMolecularFunction	kinase binding	MYH6 TPCN2 PDGFRB RBBP6 RAD54L2 IQGAP1 BICD1 MSN IBTK LATS1 PER2 TIAM1 GAB4 AKAP11 ZFYVE26 PLCB4 NOS2	8.92e-06	969	103	17	GO:0019900
GeneOntologyMolecularFunction	protein kinase binding	MYH6 TPCN2 PDGFRB RBBP6 RAD54L2 IQGAP1 BICD1 MSN IBTK LATS1 TIAM1 GAB4 AKAP11 ZFYVE26 PLCB4 NOS2	9.86e-06	873	103	16	GO:0019901
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	TPCN2 RYR1 ITPR2 ITPR3	1.89e-05	31	103	4	GO:0099604
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	TPCN2 RYR1 ITPR2 ITPR3	2.44e-05	33	103	4	GO:0005217
GeneOntologyMolecularFunction	phosphatidylinositol phosphate binding	ANKFY1 TPCN2 INPPL1 KRIT1 IQGAP1 GAB4 ZFYVE26	7.76e-05	199	103	7	GO:1901981
GeneOntologyMolecularFunction	inositol 1,4,5-trisphosphate-gated calcium channel activity	ITPR2 ITPR3	7.88e-05	3	103	2	GO:0005220
GeneOntologyMolecularFunction	phospholipid binding	ANKFY1 TPCN2 INPPL1 KRIT1 IQGAP1 ITPR2 ITPR3 TIAM1 SNX25 GAB4 ZFYVE26	1.23e-04	548	103	11	GO:0005543
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH2 MYH4 MYH6 INPPL1 STMN1 SYBU NEB TUBGCP5 KRIT1 IQGAP1 BICD1 MSN SETD2 TIAM1 FMN2 NOS2	1.55e-04	1099	103	16	GO:0008092
GeneOntologyMolecularFunction	calmodulin binding	MYH2 MYH4 MYH6 PDE1B RYR1 IQGAP1 NOS2	1.91e-04	230	103	7	GO:0005516
GeneOntologyMolecularFunction	ATPase inhibitor activity	TSC1 FNIP1	3.90e-04	6	103	2	GO:0042030
GeneOntologyMolecularFunction	actin binding	MYH2 MYH4 MYH6 INPPL1 NEB IQGAP1 MSN FMN2 NOS2	8.34e-04	479	103	9	GO:0003779
GeneOntologyMolecularFunction	microfilament motor activity	MYH2 MYH4 MYH6	9.86e-04	38	103	3	GO:0000146
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol	TPCN2 HTR2C RYR1 ITPR2 ITPR3 IBTK PLCB4	8.66e-06	146	103	7	GO:0051209
GeneOntologyBiologicalProcess	negative regulation of sequestering of calcium ion	TPCN2 HTR2C RYR1 ITPR2 ITPR3 IBTK PLCB4	9.06e-06	147	103	7	GO:0051283
GeneOntologyBiologicalProcess	regulation of sequestering of calcium ion	TPCN2 HTR2C RYR1 ITPR2 ITPR3 IBTK PLCB4	9.89e-06	149	103	7	GO:0051282
GeneOntologyBiologicalProcess	sequestering of calcium ion	TPCN2 HTR2C RYR1 ITPR2 ITPR3 IBTK PLCB4	1.18e-05	153	103	7	GO:0051208
GeneOntologyBiologicalProcess	muscle filament sliding	MYH2 MYH4 MYH6	5.27e-05	15	103	3	GO:0030049
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH2 MYH4 MYH6	9.34e-05	18	103	3	GO:0033275
GeneOntologyBiologicalProcess	calcium ion transmembrane import into cytosol	TPCN2 HTR2C RYR1 ITPR2 ITPR3 IBTK PLCB4	1.09e-04	217	103	7	GO:0097553
GeneOntologyCellularComponent	muscle myosin complex	MYH2 MYH4 MYH6	6.58e-05	16	105	3	GO:0005859
GeneOntologyCellularComponent	centrosome	IFT57 RBBP6 ANKRD26 CCDC141 TUBGCP5 BICD1 LATS1 TIAM1 PARD6A KIAA1217 AKAP11 ZFYVE26 PLK4	1.28e-04	770	105	13	GO:0005813
GeneOntologyCellularComponent	actin cytoskeleton	MYH2 MYH4 MYH6 FLT1 ANKRD26 TSC1 NEB IQGAP1 CENPQ FMN2 MYH16	1.52e-04	576	105	11	GO:0015629
GeneOntologyCellularComponent	microtubule organizing center	IFT57 RBBP6 ANKRD26 CCDC141 TUBGCP5 BICD1 LATS1 TIAM1 PARD6A USO1 KIAA1217 AKAP11 ZFYVE26 PLK4	2.02e-04	919	105	14	GO:0005815
GeneOntologyCellularComponent	myosin complex	MYH2 MYH4 MYH6 MYH16	2.21e-04	59	105	4	GO:0016459
GeneOntologyCellularComponent	myosin filament	MYH2 MYH4 MYH6	2.61e-04	25	105	3	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH2 MYH4 MYH6	3.68e-04	28	105	3	GO:0016460
GeneOntologyCellularComponent	cell cortex	MYH2 TSC1 RYR1 IQGAP1 ITPR2 PARD6A FMN2 NOS2	5.70e-04	371	105	8	GO:0005938
GeneOntologyCellularComponent	platelet dense tubular network membrane	ITPR2 ITPR3	8.79e-04	9	105	2	GO:0031095
GeneOntologyCellularComponent	platelet dense tubular network	ITPR2 ITPR3	1.33e-03	11	105	2	GO:0031094
MousePheno	abnormal male preputial gland morphology	UACA EDA LEPR PER2	1.05e-06	14	82	4	MP:0002717
MousePheno	abnormal glans penis morphology	UACA EDA LEPR PER2	1.90e-06	16	82	4	MP:0009102
MousePheno	abnormal preputial gland morphology	UACA EDA LEPR PER2	1.90e-06	16	82	4	MP:0013329
MousePheno	abnormal penis morphology	UACA EDA LEPR PER2	2.68e-05	30	82	4	MP:0005187
MousePheno	abnormal sweat gland physiology	EDA ITPR2	3.40e-05	2	82	2	MP:0013368
MousePheno	abnormal sweat gland secretion	EDA ITPR2	3.40e-05	2	82	2	MP:0013369
MousePheno	increased body size	HTR2C CYP19A1 ANKRD26 LEPR RYR1 ITPR3 PER2 USO1 KIAA1217 NOS2	1.34e-04	409	82	10	MP:0001264
Domain	Myosin-like_IQ_dom	MYH2 MYH4 MYH6 IQGAP1	2.93e-06	19	101	4	IPR027401
Domain	-	MYH2 MYH4 MYH6 IQGAP1	2.93e-06	19	101	4	4.10.270.10
Domain	RIH_assoc	RYR1 ITPR2 ITPR3	3.03e-06	6	101	3	PF08454
Domain	RIH_assoc-dom	RYR1 ITPR2 ITPR3	3.03e-06	6	101	3	IPR013662
Domain	RIH_dom	RYR1 ITPR2 ITPR3	3.03e-06	6	101	3	IPR000699
Domain	Ins145_P3_rcpt	RYR1 ITPR2 ITPR3	3.03e-06	6	101	3	IPR014821
Domain	Ryanodine_recept-rel	RYR1 ITPR2 ITPR3	3.03e-06	6	101	3	IPR015925
Domain	-	RYR1 ITPR2 ITPR3	3.03e-06	6	101	3	1.25.10.30
Domain	RYDR_ITPR	RYR1 ITPR2 ITPR3	3.03e-06	6	101	3	PF01365
Domain	Ins145_P3_rec	RYR1 ITPR2 ITPR3	3.03e-06	6	101	3	PF08709
Domain	MIR	RYR1 ITPR2 ITPR3	1.79e-05	10	101	3	PS50919
Domain	MIR	RYR1 ITPR2 ITPR3	1.79e-05	10	101	3	PF02815
Domain	MIR	RYR1 ITPR2 ITPR3	1.79e-05	10	101	3	SM00472
Domain	MIR_motif	RYR1 ITPR2 ITPR3	1.79e-05	10	101	3	IPR016093
Domain	Myosin_N	MYH2 MYH4 MYH6	6.66e-05	15	101	3	PF02736
Domain	Myosin_N	MYH2 MYH4 MYH6	6.66e-05	15	101	3	IPR004009
Domain	InsP3_rcpt-bd	ITPR2 ITPR3	8.66e-05	3	101	2	IPR000493
Domain	Myosin_tail_1	MYH2 MYH4 MYH6	1.18e-04	18	101	3	PF01576
Domain	Myosin_tail	MYH2 MYH4 MYH6	1.18e-04	18	101	3	IPR002928
Domain	HIN_200	IFI16 PYHIN1	1.73e-04	4	101	2	PS50834
Domain	HIN	IFI16 PYHIN1	1.73e-04	4	101	2	PF02760
Domain	HIN200/IF120x	IFI16 PYHIN1	1.73e-04	4	101	2	IPR004021
Domain	Ank	ANKRD31 ANKFY1 UACA ANKRD26 KRIT1 IBTK ANKS1A	2.40e-04	228	101	7	PF00023
Domain	AWS	NSD1 SETD2	2.86e-04	5	101	2	SM00570
Domain	AWS	NSD1 SETD2	2.86e-04	5	101	2	PS51215
Domain	AWS_dom	NSD1 SETD2	2.86e-04	5	101	2	IPR006560
Domain	-	ANKRD31 ANKFY1 UACA ANKRD26 KRIT1 IBTK ANKS1A	3.98e-04	248	101	7	1.25.40.20
Domain	ANK	ANKRD31 ANKFY1 UACA ANKRD26 KRIT1 IBTK ANKS1A	4.28e-04	251	101	7	SM00248
Domain	ANK_REPEAT	ANKRD31 ANKFY1 UACA ANKRD26 KRIT1 IBTK ANKS1A	4.49e-04	253	101	7	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD31 ANKFY1 UACA ANKRD26 KRIT1 IBTK ANKS1A	4.60e-04	254	101	7	IPR020683
Domain	ANK_REP_REGION	ANKRD31 ANKFY1 UACA ANKRD26 KRIT1 IBTK ANKS1A	4.60e-04	254	101	7	PS50297
Domain	Ankyrin_rpt	ANKRD31 ANKFY1 UACA ANKRD26 KRIT1 IBTK ANKS1A	5.53e-04	262	101	7	IPR002110
Domain	IQ	MYH2 MYH4 MYH6 IQGAP1	5.93e-04	71	101	4	PF00612
Domain	Tyr_kinase_rcpt_3_CS	FLT1 PDGFRB	7.94e-04	8	101	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	FLT1 PDGFRB	7.94e-04	8	101	2	PS00240
Domain	IQ	MYH2 MYH4 MYH6 IQGAP1	9.74e-04	81	101	4	SM00015
Domain	Ank_2	ANKRD31 ANKFY1 UACA ANKRD26 IBTK ANKS1A	1.11e-03	215	101	6	PF12796
Domain	Myosin_head_motor_dom	MYH2 MYH4 MYH6	1.13e-03	38	101	3	IPR001609
Domain	MYOSIN_MOTOR	MYH2 MYH4 MYH6	1.13e-03	38	101	3	PS51456
Domain	Myosin_head	MYH2 MYH4 MYH6	1.13e-03	38	101	3	PF00063
Domain	MYSc	MYH2 MYH4 MYH6	1.13e-03	38	101	3	SM00242
Domain	IQ_motif_EF-hand-BS	MYH2 MYH4 MYH6 IQGAP1	1.44e-03	90	101	4	IPR000048
Domain	IQ	MYH2 MYH4 MYH6 IQGAP1	1.63e-03	93	101	4	PS50096
Domain	Post-SET_dom	NSD1 SETD2	3.31e-03	16	101	2	IPR003616
Domain	PostSET	NSD1 SETD2	3.31e-03	16	101	2	SM00508
Domain	POST_SET	NSD1 SETD2	3.31e-03	16	101	2	PS50868
Domain	Ion_trans_dom	TPCN2 RYR1 ITPR2 ITPR3	3.41e-03	114	101	4	IPR005821
Domain	Ion_trans	TPCN2 RYR1 ITPR2 ITPR3	3.41e-03	114	101	4	PF00520
Domain	RCC1	IBTK HERC6	5.16e-03	20	101	2	PF00415
Domain	-	ECT2L MSN TIAM1 GAB4 PLCB4 APBB1IP ANKS1A	5.33e-03	391	101	7	2.30.29.30
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	HTR2C PDE1B PDGFRB RYR1 ITPR2 ITPR3 PLCB4 NOS2	7.38e-06	178	80	8	M2890
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY	ITPR2 ITPR3 PLCB4	2.05e-05	10	80	3	M47661
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY	ITPR2 ITPR3 PLCB4	2.81e-05	11	80	3	M49033
Pathway	KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY	ITPR2 ITPR3 PLCB4	4.83e-05	13	80	3	M47656
Pathway	REACTOME_PLATELET_HOMEOSTASIS	PDE1B ITPR2 ITPR3 GNB5 NOS2	6.99e-05	76	80	5	MM15051
Pathway	REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	IQGAP1 ITPR2 ITPR3 GNB5	9.14e-05	42	80	4	M791
Pathway	REACTOME_PLATELET_HOMEOSTASIS	PDE1B ITPR2 ITPR3 GNB5 NOS2	1.26e-04	86	80	5	M916
Pathway	REACTOME_OPIOID_SIGNALLING	PDE1B ITPR2 ITPR3 GNB5 PLCB4	1.56e-04	90	80	5	M6467
Pathway	KEGG_GAP_JUNCTION	HTR2C PDGFRB ITPR2 ITPR3 PLCB4	1.56e-04	90	80	5	M4013
Pathway	KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY	RYR1 ITPR2 ITPR3	1.60e-04	19	80	3	M47760
Pathway	KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY	HTR2C ITPR2 ITPR3 PLCB4	1.82e-04	50	80	4	M47951
Pathway	KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY	ITPR2 ITPR3 PLCB4	1.87e-04	20	80	3	M47688
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY	ITPR2 ITPR3 PLCB4	2.17e-04	21	80	3	M47689
Pathway	WP_HIPPO_SIGNALING_REGULATION	FLT1 PDGFRB TEAD1 LATS1 PLCB4	2.33e-04	98	80	5	M39830
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	PDE1B ITPR2 ITPR3 PLCB4	2.45e-04	54	80	4	M26911
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY	ITPR2 ITPR3 PLCB4	2.51e-04	22	80	3	M47690
Pathway	KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY	ITPR2 ITPR3 PLCB4	2.51e-04	22	80	3	M47675
Pathway	KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY	FLT1 PDGFRB ITPR2 ITPR3	2.63e-04	55	80	4	M47952
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY	ITPR2 ITPR3 PLCB4	2.87e-04	23	80	3	M47676
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY	ITPR2 ITPR3	3.15e-04	5	80	2	M49000
Pathway	KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY	ITPR2 ITPR3	4.70e-04	6	80	2	M47960
Pathway	WP_HIPPOMERLIN_SIGNALING_DYSREGULATION	FLT1 PDGFRB TEAD1 LATS1 PLCB4	6.17e-04	121	80	5	M39823
Pathway	KEGG_LONG_TERM_DEPRESSION	RYR1 ITPR2 ITPR3 PLCB4	6.64e-04	70	80	4	M8232
Pathway	REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	ITPR2 ITPR3 GNB5	7.75e-04	32	80	3	MM14983
Pathway	WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY	RYR1 ITPR2 ITPR3 NOS2	8.19e-04	74	80	4	M48080
Pathway	KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	INPPL1 ITPR2 ITPR3 PLCB4	9.05e-04	76	80	4	M9052
Pathway	REACTOME_RHO_GTPASE_CYCLE	ANKFY1 UACA RBBP6 ANKRD26 ARHGAP11A IQGAP1 TIAM1 PARD6A GOLGA3	9.89e-04	450	80	9	M27078
Pathway	REACTOME_REGULATION_OF_INSULIN_SECRETION	IQGAP1 ITPR2 ITPR3 GNB5	9.98e-04	78	80	4	M1921
Pathway	KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY	ITPR2 ITPR3	1.12e-03	9	80	2	M47852
Pathway	WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS	FLT1 PDGFRB TSC1 SETD2	1.44e-03	86	80	4	M39375
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	EPRS1 STMN1 HNRNPH1 IQGAP1 MSN ITPR3 USO1 KIAA1217 ACAA2 GOLGA3	1.65e-07	360	106	10	33111431
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DMXL2 ANKFY1 PDE1B CCT3 UACA NSD1 TSC1 SLC1A2 IQGAP1 MSN MDN1 KIAA1217 DZIP3 GOLGA3 ANKS1A	2.40e-07	963	106	15	28671696
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	DMXL2 ANKFY1 UACA ANKRD26 ZNF407 TEAD1 NEB CCDC141 RYR1 MSN ACAA2	3.73e-07	497	106	11	23414517
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	EPRS1 MYH4 CCT3 CCDC73 ZNF622 ZNF226 ARHGAP11A HNRNPH1 RYR1 ITPR2 MDN1 FMN2 DOP1B	4.02e-07	736	106	13	29676528
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR1 ITPR2 ITPR3	5.47e-07	6	106	3	23463619
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR1 ITPR2 ITPR3	5.47e-07	6	106	3	25966694
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR1 ITPR2 ITPR3	5.47e-07	6	106	3	20519450
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR1 ITPR2 ITPR3	5.47e-07	6	106	3	16844763
Pubmed	Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.	RYR1 ITPR2 ITPR3	9.55e-07	7	106	3	11860456
Pubmed	Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes.	LEPR ITPR2 ITPR3	9.55e-07	7	106	3	22495310
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH2 MYH4 MYH6	9.55e-07	7	106	3	16819597
Pubmed	A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning.	MYH2 MYH4 MYH6	1.52e-06	8	106	3	14667415
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR1 ITPR2 ITPR3	1.52e-06	8	106	3	19033399
Pubmed	C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways.	ANKFY1 CCT3 HNRNPH1 GTF2I USO1 GOLGA3	1.82e-06	119	106	6	35776542
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	INPPL1 ANKRD26 LATS1 MDN1 TIAM1 USO1 KIAA1217 FMN2 FNIP1 AKAP11 PLK4 DOP1B ANKS1A	2.29e-06	861	106	13	36931259
Pubmed	Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6.	MYH2 MYH4 MYH6 TEAD1	2.41e-06	31	106	4	21985497
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	EPRS1 MYH4 CCT3 UACA IQGAP1 ITPR3 TIAM1	3.01e-06	202	106	7	33005030
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	DMXL2 TSC1 BICD1 ITPR2 ITPR3 FMN2 FNIP1 AKAP11 GOLGA3 DOP1B	3.44e-06	504	106	10	34432599
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	INPPL1 IBTK USO1 FNIP1 AKAP11 GOLGA3 ANKS1A	3.77e-06	209	106	7	36779422
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EPRS1 CCT3 RBBP6 ANKRD26 ZNF622 TSC1 STMN1 HNRNPH1 IBTK SETD2 GTF2I KIAA1217 ANKS1A	5.54e-06	934	106	13	33916271
Pubmed	Network organization of the human autophagy system.	MYH2 MYH4 ANKFY1 CCT3 TSC1 IQGAP1 DZIP3 FNIP1 GOLGA3	8.06e-06	437	106	9	20562859
Pubmed	Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin.	ITPR2 ITPR3	9.20e-06	2	106	2	9065779
Pubmed	NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas.	NSD1 SETD2	9.20e-06	2	106	2	28754676
Pubmed	Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.	NSD1 SETD2	9.20e-06	2	106	2	31060750
Pubmed	ER stress increases expression of intracellular calcium channel RyR1 to modify Ca2+ homeostasis in pancreatic beta cells.	LEPR RYR1	9.20e-06	2	106	2	37468098
Pubmed	Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	9.20e-06	2	106	2	8081734
Pubmed	The phenotype of vascular smooth muscle cells co-cultured with endothelial cells is modulated by PDGFR-β/IQGAP1 signaling in LPS-induced intravascular injury.	PDGFRB IQGAP1	9.20e-06	2	106	2	31523178
Pubmed	Molecular cloning of mouse type 2 and type 3 inositol 1,4,5-trisphosphate receptors and identification of a novel type 2 receptor splice variant.	ITPR2 ITPR3	9.20e-06	2	106	2	15632133
Pubmed	Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.	TSC1 SLC1A2	9.20e-06	2	106	2	20045054
Pubmed	Serotonin receptor 2C and insulin secretion.	HTR2C LEPR	9.20e-06	2	106	2	23349838
Pubmed	Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve.	ITPR2 ITPR3	9.20e-06	2	106	2	17496801
Pubmed	Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye.	ITPR2 ITPR3	9.20e-06	2	106	2	24901844
Pubmed	Adrenergic inhibition facilitates normalization of extracellular potassium after cortical spreading depolarization.	ITPR2 ITPR3	9.20e-06	2	106	2	33854148
Pubmed	The Novel Pathogenesis of Retinopathy Mediated by Multiple RTK Signals is Uncovered in Newly Developed Mouse Model.	FLT1 PDGFRB	9.20e-06	2	106	2	29724654
Pubmed	Pancreatic protease activation by alcohol metabolite depends on Ca2+ release via acid store IP3 receptors.	ITPR2 ITPR3	9.20e-06	2	106	2	19528657
Pubmed	Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction.	ITPR2 ITPR3	9.20e-06	2	106	2	8063813
Pubmed	IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism.	ITPR2 ITPR3	9.20e-06	2	106	2	16195467
Pubmed	Common allosteric mechanisms between ryanodine and inositol-1,4,5-trisphosphate receptors.	RYR1 ITPR3	9.20e-06	2	106	2	21150295
Pubmed	Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling.	MYH2 MYH4	9.20e-06	2	106	2	21102503
Pubmed	Inositol (1,4,5)-trisphosphate receptor links to filamentous actin are important for generating local Ca2+ signals in pancreatic acinar cells.	ITPR2 ITPR3	9.20e-06	2	106	2	15713744
Pubmed	Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.	FLT1 PDGFRB	9.20e-06	2	106	2	15665766
Pubmed	Lethal multiple pterygium syndrome, large cystic hygroma, and cleft palate: Rare and severe fetal presentations of RYR1- and NEB-related congenital myopathies.	NEB RYR1	9.20e-06	2	106	2	38520674
Pubmed	Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation.	NSD1 SETD2	9.20e-06	2	106	2	18157086
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH2 MYH4 MYH6	9.77e-06	14	106	3	24938781
Pubmed	Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle.	ITPR2 ITPR3 PLCB4	1.22e-05	15	106	3	28578927
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	FLT1 PDGFRB INPPL1 CYP19A1 TSC1 LEPR LATS1 NOS2	1.27e-05	351	106	8	20453000
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH2 MYH4 MYH6	1.50e-05	16	106	3	19922871
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EPRS1 UACA RBBP6 IFI16 HNRNPH1 IQGAP1 SETD2 LATS1 GTF2I MDN1 ANKS1A	2.52e-05	774	106	11	15302935
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH2 MYH4	2.76e-05	3	106	2	26059207
Pubmed	Evidence that type I, II, and III inositol 1,4,5-trisphosphate receptors can occur as integral plasma membrane proteins.	ITPR2 ITPR3	2.76e-05	3	106	2	10874040
Pubmed	Abnormal distribution of inositol 1,4,5-trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy-derived cells.	ITPR2 ITPR3	2.76e-05	3	106	2	20395455
Pubmed	Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication.	HTR2C LEPR	2.76e-05	3	106	2	20562674
Pubmed	Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases.	ITPR2 ITPR3	2.76e-05	3	106	2	17437169
Pubmed	Decreased olfactory mucus secretion and nasal abnormality in mice lacking type 2 and type 3 IP3 receptors.	ITPR2 ITPR3	2.76e-05	3	106	2	18547250
Pubmed	Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population.	ITPR2 ITPR3	2.76e-05	3	106	2	36350267
Pubmed	The versatility and universality of calcium signalling.	ITPR2 ITPR3	2.76e-05	3	106	2	11413485
Pubmed	Using concatenated subunits to investigate the functional consequences of heterotetrameric inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	2.76e-05	3	106	2	26009177
Pubmed	Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.	HTR2C LEPR	2.76e-05	3	106	2	18477467
Pubmed	Receptor-activated single channels in intact human platelets.	ITPR2 ITPR3	2.76e-05	3	106	2	1693919
Pubmed	Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.	ITPR2 ITPR3	2.76e-05	3	106	2	23955339
Pubmed	Type 3 Inositol 1,4,5-Trisphosphate Receptor is a Crucial Regulator of Calcium Dynamics Mediated by Endoplasmic Reticulum in HEK Cells.	ITPR2 ITPR3	2.76e-05	3	106	2	31979185
Pubmed	YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation.	PDGFRB TEAD1	2.76e-05	3	106	2	33753119
Pubmed	Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly.	ITPR2 ITPR3	2.76e-05	3	106	2	24904548
Pubmed	ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.	MYH2 MYH4	2.76e-05	3	106	2	23339872
Pubmed	Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.	PDGFRB INPPL1	2.76e-05	3	106	2	18814181
Pubmed	The myosin alkali light chain proteins and their genes.	MYH2 MYH4	2.76e-05	3	106	2	3904738
Pubmed	Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation.	TSC1 FNIP1	2.76e-05	3	106	2	29897930
Pubmed	The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.	INPPL1 LEPR	2.76e-05	3	106	2	20829391
Pubmed	Leptin, its receptor and aromatase expression in deep infiltrating endometriosis.	CYP19A1 LEPR	2.76e-05	3	106	2	26242176
Pubmed	Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes.	ITPR2 ITPR3	2.76e-05	3	106	2	9858485
Pubmed	Intestinal mTOR regulates GLP-1 production in mouse L cells.	TSC1 LEPR	2.76e-05	3	106	2	26037201
Pubmed	Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland.	ITPR2 ITPR3	2.76e-05	3	106	2	21435446
Pubmed	Expression of inositol 1,4,5-trisphosphate receptors in mouse oocytes and early embryos: the type I isoform is upregulated in oocytes and downregulated after fertilization.	ITPR2 ITPR3	2.76e-05	3	106	2	9808793
Pubmed	Type 2 and type 3 inositol 1,4,5-trisphosphate (IP3) receptors promote the differentiation of granule cell precursors in the postnatal cerebellum.	ITPR2 ITPR3	2.76e-05	3	106	2	18194433
Pubmed	Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles.	MYH2 MYH4	2.76e-05	3	106	2	8145163
Pubmed	IP3 receptors regulate vascular smooth muscle contractility and hypertension.	ITPR2 ITPR3	2.76e-05	3	106	2	27777977
Pubmed	Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions.	INPPL1 ANKS1A	2.76e-05	3	106	2	29749928
Pubmed	Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line.	ITPR2 ITPR3	2.76e-05	3	106	2	17581770
Pubmed	Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction.	ITPR2 ITPR3	2.76e-05	3	106	2	18241669
Pubmed	Granulosa cells express three inositol 1,4,5-trisphosphate receptor isoforms: cytoplasmic and nuclear Ca2+ mobilization.	ITPR2 ITPR3	2.76e-05	3	106	2	19068129
Pubmed	Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors.	ITPR2 ITPR3	2.76e-05	3	106	2	17327232
Pubmed	Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels.	HTR2C LEPR	2.76e-05	3	106	2	21835345
Pubmed	mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.	TSC1 LEPR	2.76e-05	3	106	2	21606597
Pubmed	Type 1 inositol (1,4,5)-trisphosphate receptor activates ryanodine receptor 1 to mediate calcium spark signaling in adult mammalian skeletal muscle.	RYR1 ITPR2	2.76e-05	3	106	2	23223241
Pubmed	Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation.	ITPR2 ITPR3	2.76e-05	3	106	2	16014380
Pubmed	Combined HTR2C-LEP and HTR2C-LEPR genotypes as a determinant for obesity in patients without antipsychotic drugs.	HTR2C LEPR	2.76e-05	3	106	2	24525657
Pubmed	A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle.	EDA LEPR	2.76e-05	3	106	2	29106399
Pubmed	Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice.	ITPR2 ITPR3	2.76e-05	3	106	2	17890015
Pubmed	Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.	ITPR2 ITPR3	2.76e-05	3	106	2	23983250
Pubmed	Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle.	MYH2 MYH4	2.76e-05	3	106	2	15013776
Pubmed	Activation of the inositol (1,4,5)-triphosphate calcium gate receptor is required for HIV-1 Gag release.	ITPR2 ITPR3	2.76e-05	3	106	2	20427533
Pubmed	Tuberous sclerosis complex: disease modifiers and treatments.	HTR2C TSC1	2.76e-05	3	106	2	19005330
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EPRS1 MYH2 MYH4 MYH6 CCT3 ZNF658 ANKRD26 TSC1 RAD54L2 NEB IQGAP1 MSN LATS1 MDN1 SNX25	3.21e-05	1442	106	15	35575683
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	EPRS1 DMXL2 PDGFRB STMN1 RAD54L2 TUBGCP5 KRIT1 IQGAP1 BICD1 TIAM1 ZNF197 FMN2 GOLGA3 DOP1B	3.66e-05	1285	106	14	35914814
Pubmed	A new role for the calcineurin/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2/MyoD complex during mouse myogenesis.	MYH2 MYH4 MYH6	4.06e-05	22	106	3	24301466
Pubmed	Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages.	ITPR2 ITPR3 PLCB4	5.32e-05	24	106	3	10843712
Pubmed	Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.	RYR1 ITPR3	5.50e-05	4	106	2	22100703
Pubmed	Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia.	ITPR2 ITPR3	5.50e-05	4	106	2	25215520
Pubmed	Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor.	ITPR2 ITPR3	5.50e-05	4	106	2	17925404
Pubmed	Centriole signaling restricts hepatocyte ploidy to maintain liver integrity.	ANKRD26 PLK4	5.50e-05	4	106	2	35981754
Interaction	ABTB2 interactions	MYH2 MYH4 MYH6 IFT57 NEB HNRNPH1 SETD2 TIAM1	4.47e-08	101	102	8	int:ABTB2
Interaction	CAMK2G interactions	TSC1 STMN1 NHLRC2 RYR1 IQGAP1 ITPR2 ITPR3 TIAM1 NOS2	3.63e-06	240	102	9	int:CAMK2G
Interaction	PFN1 interactions	ANKFY1 INPPL1 ANKRD26 TSC1 STMN1 NHLRC2 KIAA1217 FMN2 ACAA2 GOLGA3 APBB1IP DOP1B	1.02e-05	509	102	12	int:PFN1
Interaction	FBXW11 interactions	EPRS1 SYBU IFI16 TUBGCP5 HNRNPH1 PYHIN1 GTF2I PER2 TIAM1 FNIP1 PLK4	2.76e-05	473	102	11	int:FBXW11
Interaction	YWHAZ interactions	DMXL2 PDE1B UACA COL6A6 RNF8 ANKRD26 TSC1 NEB IFI16 MSN LATS1 PER2 TIAM1 PARD6A AKAP11 NOS2 PLK4 GOLGA3 ANKS1A	3.04e-05	1319	102	19	int:YWHAZ
Interaction	ACTN4 interactions	EPRS1 MYH2 MYH6 ANKFY1 INPPL1 NEB HNRNPH1 IQGAP1 PER2 NOS2	3.56e-05	400	102	10	int:ACTN4
Interaction	GJA1 interactions	MYH6 HTR2C UACA ANKRD26 ITPR2 ITPR3 GTF2I TIAM1 USO1 KIAA1217 PLK4 GOLGA3	3.87e-05	583	102	12	int:GJA1
Interaction	IRAG1 interactions	ITPR2 ITPR3 GTF2I	4.40e-05	14	102	3	int:IRAG1
Interaction	RNF123 interactions	EPRS1 MYH4 CCT3 CCDC73 ZNF622 ZNF226 ARHGAP11A HNRNPH1 RYR1 ITPR2 MDN1 ATAD1 FMN2 DOP1B	6.88e-05	824	102	14	int:RNF123
Interaction	HOMER3 interactions	IFT57 TSC1 NHLRC2 CCDC141 HNRNPH1 RYR1	7.86e-05	140	102	6	int:HOMER3
Interaction	HOMER1 interactions	IFT57 NHLRC2 RAD54L2 RYR1 CENPQ PLCB4	7.86e-05	140	102	6	int:HOMER1
Interaction	LRRC31 interactions	EPRS1 MYH4 CCT3 UACA IQGAP1 ITPR3 TIAM1	8.30e-05	205	102	7	int:LRRC31
Interaction	RASSF8 interactions	EDA BICD1 SETD2 LATS1 PARD6A	9.91e-05	91	102	5	int:RASSF8
Interaction	PGK1 interactions	COL6A6 INPPL1 STMN1 NHLRC2 CCDC7 PYHIN1 MSN PER2 ACAA2	1.03e-04	367	102	9	int:PGK1
Interaction	CIAO1 interactions	CCT3 RBBP6 TSC1 NEB HNRNPH1 CCDC7 ACAA2 GOLGA3	1.11e-04	289	102	8	int:CIAO1
Cytoband	3q13.13	IFT57 HHLA2 DZIP3	7.72e-06	17	105	3	3q13.13
GeneFamily	Myosin heavy chains	MYH2 MYH4 MYH6 MYH16	2.88e-07	15	71	4	1098
GeneFamily	Ankyrin repeat domain containing	ANKRD31 ANKFY1 UACA ANKRD26 KRIT1 IBTK ANKS1A	4.53e-05	242	71	7	403
GeneFamily	Inositol 1,4,5-triphosphate receptors\|Protein phosphatase 1 regulatory subunits	ITPR2 ITPR3	4.55e-05	3	71	2	297
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	IFI16 PYHIN1	1.51e-04	5	71	2	995
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	IFI16 PYHIN1	4.30e-03	25	71	2	994
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	RYR1 ITPR3 DZIP3 AKAP11	5.60e-03	181	71	4	694
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	ANKFY1 ZFYVE26	6.57e-03	31	71	2	81
GeneFamily	Immunoglobulin like domain containing	FLT1 PDGFRB CCDC141 LEPR	7.01e-03	193	71	4	594
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	NSD1 SETD2	7.86e-03	34	71	2	487
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DMXL2 GALK2 TEAD1 ARHGAP11A KRIT1 BICD1 IBTK SETD2 MDN1 TIAM1 AKAP11 PLCB4 DOP1B ANKS1A	5.85e-06	856	102	14	M4500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	DMXL2 CCDC73 TSC1 DZIP3 AKAP11 STAG3	1.20e-05	110	98	6	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500	DMXL2 CCDC73 SYBU DZIP3 TERB1 FNIP1	3.69e-05	134	98	6	gudmap_developingGonad_e18.5_ovary_500_k1
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA ZNF366 LEPR BICD1 KIAA1217 PLCB4	3.83e-07	193	105	7	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA ZNF366 LEPR BICD1 KIAA1217 PLCB4	3.83e-07	193	105	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 UACA ZNF366 SYBU LEPR XAF1 PLCB4	3.83e-07	193	105	7	2e72309607902dabe3218888b22a77fe941f3570
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLT1 UACA ZNF366 LEPR KIAA1217 XAF1 PLCB4	4.54e-07	198	105	7	1d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	UACA STMN1 LEPR GTF2I TIAM1 KIAA1217 PLCB4	4.70e-07	199	105	7	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLT1 UACA ZNF366 IFI16 LEPR KIAA1217 PLCB4	4.86e-07	200	105	7	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	COVID-19_Severe-NK_activated\|COVID-19_Severe / Disease condition and Cell class	UACA PDGFRB IFI16 PYHIN1 MSN XAF1 HERC6	4.86e-07	200	105	7	f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLT1 UACA ZNF366 IFI16 LEPR KIAA1217 PLCB4	4.86e-07	200	105	7	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 ZNF366 XAF1 HERC6 NOS2 ANKS1A	3.04e-06	169	105	6	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STMN1 LEPR BICD1 GTF2I KIAA1217 PLCB4	3.97e-06	177	105	6	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 UACA EDA KIAA1217 PLCB4 NOS2	4.66e-06	182	105	6	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA SYBU KIAA1217 XAF1 PLCB4 HERC6	4.81e-06	183	105	6	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT57 HNRNPH1 CFAP65 PER2 DZIP3 OSCP1	4.96e-06	184	105	6	2df903924df9cb71039159416bcbe6a6614e21fe
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	FLT1 ZNF366 LEPR KIAA1217 PLCB4 ANKS1A	5.44e-06	187	105	6	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA ZNF366 LEPR BICD1 PLCB4	5.61e-06	188	105	6	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 UACA ZNF366 LEPR XAF1 PLCB4	5.78e-06	189	105	6	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 UACA EDA KIAA1217 PLCB4 NOS2	6.14e-06	191	105	6	f229abf69a1217194f74b0502486907e07dba989
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	UACA ZNF366 IFI16 LEPR XAF1 PLCB4	6.33e-06	192	105	6	56b021c297a21dff357531f21e2464f85186106d
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA ZNF366 LEPR KIAA1217 PLCB4	6.52e-06	193	105	6	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA LEPR BICD1 KIAA1217 PLCB4	6.52e-06	193	105	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 UACA LEPR BICD1 KIAA1217 PLCB4	6.72e-06	194	105	6	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA LEPR BICD1 KIAA1217 PLCB4	6.72e-06	194	105	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 UACA ZNF366 IFI16 LEPR PLCB4	6.92e-06	195	105	6	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLT1 UACA LEPR KIAA1217 XAF1 PLCB4	7.12e-06	196	105	6	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLT1 UACA ZNF366 LEPR KIAA1217 PLCB4	7.33e-06	197	105	6	b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLT1 UACA ZNF366 KIAA1217 XAF1 PLCB4	7.55e-06	198	105	6	a1ccbf0e653b2dd665c2254920eb9b37243cc0bd
ToppCell	Severe-B_intermediate-10\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	IFT57 NEB CCDC141 RYR1 PYHIN1 XAF1	7.55e-06	198	105	6	dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLT1 UACA IFI16 LEPR KIAA1217 PLCB4	7.99e-06	200	105	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FLT1 UACA ZNF366 IFI16 LEPR KIAA1217	7.99e-06	200	105	6	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FLT1 UACA IFI16 LEPR KIAA1217 PLCB4	7.99e-06	200	105	6	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLT1 UACA ZNF366 IFI16 KIAA1217 PLCB4	7.99e-06	200	105	6	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	PDGFRB IFI16 PYHIN1 MSN XAF1 HERC6	7.99e-06	200	105	6	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLT1 UACA ZNF366 IFI16 KIAA1217 PLCB4	7.99e-06	200	105	6	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLT1 UACA ZNF366 IFI16 KIAA1217 PLCB4	7.99e-06	200	105	6	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	Control_saline-Endothelial-Endothelial-Activated_Alv_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	UACA IFI16 MSN KIAA1217 XAF1 HERC6	7.99e-06	200	105	6	be55cef682ba87250dad97689332c8820b3a7420
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLT1 UACA ZNF366 IFI16 KIAA1217 PLCB4	7.99e-06	200	105	6	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NHLRC2 BICD1 KIAA1217 DZIP3 PLCB4 OSCP1	7.99e-06	200	105	6	be46efc899d06c55ee297bee3126f69bcdb2048b
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDGFRB CCDC141 ITPR2 MSN VSTM4	3.33e-05	155	105	5	ced64e26962c5c6e6d539f361fe57ab0b399e999
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDGFRB CCDC141 ITPR2 MSN VSTM4	3.33e-05	155	105	5	0f24ef6486aef354f0911c06932cb01d1a0525ac
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDGFRB CCDC141 ITPR2 MSN VSTM4	3.33e-05	155	105	5	d8b5145258f075b15080f8739f537f48dd22225e
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UACA ZNF366 CCDC141 MSN	4.36e-05	164	105	5	6a41a159134e605b80d5e731f9ed5bc803bb531b
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UACA ZNF366 CCDC141 MSN	4.36e-05	164	105	5	ec68954fc09b6850273b5e59caa6b09d02151097
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UACA ZNF366 CCDC141 MSN	4.61e-05	166	105	5	27af6c906cff1d40d134f0386db7708869691121
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT1 CCT3 RNF8 NHLRC2 GNB5	4.88e-05	168	105	5	c7021748003e5949f7caf7b3291c5bad294948c1
ToppCell	368C-Lymphocytic-ILC\|368C / Donor, Lineage, Cell class and subclass (all cells)	TPCN2 CCDC7 CENPQ MDN1 DOP1B	5.31e-05	171	105	5	3b3143e4aa6520ee9c6b6f2482206ad3d8205d14
ToppCell	368C-Lymphocytic-ILC-ILC-2\|368C / Donor, Lineage, Cell class and subclass (all cells)	TPCN2 CCDC7 CENPQ MDN1 DOP1B	5.31e-05	171	105	5	fd01076574dcc82bfd4a1538812500543b16794f
ToppCell	Severe-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	IFT57 NEB CCDC141 RYR1 XAF1	6.43e-05	178	105	5	b7374a97c51239782bed658381a02cb1b3d9bf66
ToppCell	368C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TPCN2 CCDC7 CENPQ MDN1 DOP1B	6.77e-05	180	105	5	eb5a57604c7f2ad256c300085dbf5069d0ae1ad0
ToppCell	Ciliated_cells-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	ECT2L CFAP65 FMN2 OSCP1 CCDC40	6.77e-05	180	105	5	bdea5ec6b60fc8c7cce4d71db5da74ac8675e211
ToppCell	368C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TPCN2 CCDC7 CENPQ MDN1 DOP1B	6.77e-05	180	105	5	ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UACA SYBU ITPR2 PLCB4	6.95e-05	181	105	5	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UACA SYBU ITPR2 PLCB4	7.14e-05	182	105	5	81279877b920b5a1bc991a07d3031d6458700fe3
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	ANKFY1 IQGAP1 MSN ITPR3 DOP1B	7.51e-05	184	105	5	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	ECT2L CFAP65 HHLA2 FMN2 CCDC40	7.71e-05	185	105	5	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 NSD1 SYBU ITPR2 PLCB4	7.91e-05	186	105	5	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	EPRS1 DMXL2 ANKFY1 ITPR2 DOP1B	7.91e-05	186	105	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UACA SYBU PLCB4 NOS2	8.32e-05	188	105	5	ed11e26ff4ef3d6314b5f5734062519b9aa285c1
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	ECT2L CFAP65 HHLA2 FMN2 CCDC40	8.32e-05	188	105	5	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 LEPR BICD1 KIAA1217 PLCB4	8.32e-05	188	105	5	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UACA SYBU PLCB4 NOS2	8.32e-05	188	105	5	e5a8ca4613ab0bf1584b9e78959adf41d0bf379f
ToppCell	facs-Heart-LV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UACA SYBU PLCB4 NOS2	8.32e-05	188	105	5	0fc3a6562e6895f6fe7a93397eae842a75c60c93
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ECT2L CFAP65 HHLA2 FMN2 CCDC40	8.53e-05	189	105	5	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLT1 UACA EDA KIAA1217 XAF1	8.53e-05	189	105	5	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	CF-Lymphoid-B_cell\|CF / Disease state, Lineage and Cell class	IFT57 CCDC141 MDN1 SNX25 AKAP11	8.74e-05	190	105	5	374d8fd63c733178acab07682ed1519693efab45
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 UACA EDA KIAA1217 PLCB4	8.74e-05	190	105	5	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 ZNF366 SYBU LEPR XAF1	9.18e-05	192	105	5	bacbaef1f230051335f4433e55db07a161b96b4c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 ZNF366 IFI16 XAF1 PLCB4	9.18e-05	192	105	5	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA ZNF366 KIAA1217 PLCB4	9.18e-05	192	105	5	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	FLT1 UACA EDA KIAA1217 NOS2	9.18e-05	192	105	5	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCT3 PDGFRB STMN1 GTF2I ANKS1A	9.18e-05	192	105	5	03dcd9405d3d76fc7455066ba5d83c09cd17072d
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA ZNF366 KIAA1217 PLCB4	9.18e-05	192	105	5	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA ZNF366 KIAA1217 PLCB4	9.41e-05	193	105	5	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA LEPR KIAA1217 PLCB4	9.41e-05	193	105	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA LEPR KIAA1217 PLCB4	9.41e-05	193	105	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA ZNF366 KIAA1217 PLCB4	9.41e-05	193	105	5	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IFI16 PYHIN1 DZIP3 XAF1 HERC6	9.41e-05	193	105	5	fce4f805e53669acb4c188f87ac7d84408c0c218
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	IFI16 PYHIN1 DZIP3 XAF1 HERC6	9.41e-05	193	105	5	6e1498153a7766c03fddbda1701dbf1596d21736
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DMXL2 CCDC141 EDA RYR1 APBB1IP	9.41e-05	193	105	5	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FLT1 ZNF366 CCDC141 LEPR BICD1	9.41e-05	193	105	5	01c71aa48875b5ad6c50cc810a72862e72f26ad0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DMXL2 CCDC141 EDA RYR1 APBB1IP	9.41e-05	193	105	5	374d0526a071e973c3f43b4564f78f6933bb67ed
ToppCell	ASK440-Epithelial-Ciliated\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	ECT2L CFAP65 DZIP3 OSCP1 CCDC40	9.41e-05	193	105	5	a0baa8be6f590b2031fede22be588715ae458e93
ToppCell	CF-Lymphoid\|CF / Disease state, Lineage and Cell class	IFT57 PYHIN1 MDN1 SNX25 AKAP11	9.41e-05	193	105	5	11de07d13a7da223990b56fa89ba7fc1c3dd0122
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	STMN1 ARHGAP11A PYHIN1 ACAA2 PLK4	9.64e-05	194	105	5	17af04acd54dd6a895a966cbb4422de25dc4f1e6
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	STMN1 ARHGAP11A PYHIN1 ACAA2 PLK4	9.64e-05	194	105	5	3c385d93c5fe1a7817813c492f79fdb94d887357
ToppCell	normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T\|normal_Pleural_Fluid / Location, Cell class and cell subclass	PYHIN1 MSN DZIP3 ACAA2 APBB1IP	9.64e-05	194	105	5	68a9e00c9e1a855eeebfc26c038652f3800758db
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 UACA LEPR KIAA1217 PLCB4	9.64e-05	194	105	5	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA LEPR KIAA1217 PLCB4	9.64e-05	194	105	5	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	STMN1 ARHGAP11A PYHIN1 ACAA2 PLK4	9.64e-05	194	105	5	635d0e88f9c542a1d9363066c6cdbc6e44db76c1
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 UACA LEPR KIAA1217 PLCB4	9.64e-05	194	105	5	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 NSD1 IQGAP1 FMN2 FNIP1	9.87e-05	195	105	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	FLT1 UACA ZNF366 KIAA1217 XAF1	9.87e-05	195	105	5	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 ZNF366 IFI16 XAF1 PLCB4	9.87e-05	195	105	5	77e47d2e8b3eb7f7c9620369ccaf87581f923bdb
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ECT2L CFAP65 DZIP3 OSCP1 CCDC40	1.01e-04	196	105	5	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT1 UACA ZNF366 KIAA1217 XAF1	1.01e-04	196	105	5	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FLT1 ZNF366 CCDC141 LEPR BICD1	1.01e-04	196	105	5	81278e696d823744267d6315c4d42799c4ea0b2c
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT1 ZNF366 LEPR KIAA1217 XAF1	1.01e-04	196	105	5	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	FLT1 UACA ZNF366 EDA KIAA1217	1.01e-04	196	105	5	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	Endothelial-capillary_endothelial_cell_(Cap1)\|World / Lineage, Cell type, age group and donor	FLT1 UACA LEPR KIAA1217 PLCB4	1.01e-04	196	105	5	0ce3ed27d2b9276390952652c17a8d6de13add36
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FLT1 UACA PDGFRB IFI16 XAF1	1.04e-04	197	105	5	66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	FLT1 IFI16 LEPR KIAA1217 ANKS1A	1.04e-04	197	105	5	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
Drug	AC1L1CR9	RYR1 MSN ITPR3 PLCB4	2.14e-06	21	102	4	CID000002023
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	ANKFY1 SYBU RAD54L2 TUBGCP5 CEPT1 GTF2I PER2 GNB5	2.87e-06	196	102	8	7552_UP
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH4 MYH6	4.45e-06	10	100	3	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH4 MYH6	4.45e-06	10	100	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH4 MYH6	4.45e-06	10	100	3	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH4 MYH6	4.45e-06	10	100	3	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH4 MYH6	4.45e-06	10	100	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH4 MYH6	4.45e-06	10	100	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH4 MYH6	4.45e-06	10	100	3	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH4 MYH6	4.45e-06	10	100	3	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH4 MYH6	8.13e-06	12	100	3	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH4 MYH6	8.13e-06	12	100	3	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH4 MYH6	1.05e-05	13	100	3	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH4 MYH6	1.67e-05	15	100	3	DOID:0050646 (implicated_via_orthology)
Disease	Sotos' syndrome	NSD1 SETD2	6.79e-05	4	100	2	C0175695
Disease	Sarcomatoid Renal Cell Carcinoma	FLT1 TSC1 RYR1 SETD2 FMN2	7.69e-05	128	100	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	FLT1 TSC1 RYR1 SETD2 FMN2	7.69e-05	128	100	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	FLT1 TSC1 RYR1 SETD2 FMN2	7.69e-05	128	100	5	C1266044
Disease	Papillary Renal Cell Carcinoma	FLT1 TSC1 RYR1 SETD2 FMN2	7.69e-05	128	100	5	C1306837
Disease	Renal Cell Carcinoma	FLT1 TSC1 RYR1 SETD2 FMN2	7.69e-05	128	100	5	C0007134
Disease	preeclampsia, fetal genotype effect measurement	FLT1 ITPR2	1.13e-04	5	100	2	EFO_0000668, EFO_0007959
Disease	smoking cessation	IFT57 CCDC141 LEPR ITPR3 HHLA2 KIAA1217 ANKS1A	1.23e-04	325	100	7	EFO_0004319
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	FLT1 TSC1 RYR1 SETD2 FMN2	1.52e-04	148	100	5	C0279702
Disease	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	NEB RYR1	1.69e-04	6	100	2	C1854678
Disease	retinal disease (implicated_via_orthology)	CEPT1 PLCB4	1.69e-04	6	100	2	DOID:5679 (implicated_via_orthology)
Disease	Mental Depression	HTR2C PDE1B STMN1 SLC1A2 PER2 NOS2	2.33e-04	254	100	6	C0011570
Disease	neutrophil percentage of leukocytes	ZNF366 CYP19A1 IFI16 LEPR HNRNPH1 IQGAP1 VSTM4 SETD2 AKAP11	2.33e-04	610	100	9	EFO_0007990
Disease	Leydig cell tumor (is_marker_for)	FLT1 PDGFRB	3.14e-04	8	100	2	DOID:2696 (is_marker_for)
Disease	Gestational Diabetes	CYP19A1 LEPR	4.03e-04	9	100	2	C0085207
Disease	lymphocyte percentage of leukocytes	ZNF366 CYP19A1 IFI16 LEPR HNRNPH1 IQGAP1 VSTM4 SETD2 APBB1IP	4.37e-04	665	100	9	EFO_0007993
Disease	Depressive disorder	HTR2C PDE1B STMN1 SLC1A2 PER2 NOS2	4.62e-04	289	100	6	C0011581
Disease	myopathy (implicated_via_orthology)	MYH2 MYH4 MYH6	5.85e-04	48	100	3	DOID:423 (implicated_via_orthology)
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR2 ITPR3	7.34e-04	12	100	2	DOID:1441 (implicated_via_orthology)
Disease	retinopathy of prematurity (biomarker_via_orthology)	FLT1 NOS2	7.34e-04	12	100	2	DOID:13025 (biomarker_via_orthology)
Disease	Congenital myopathy (disorder)	NEB RYR1	7.34e-04	12	100	2	C0270960
Disease	obesity (implicated_via_orthology)	ANKRD26 TSC1 LEPR ITPR2 ITPR3	8.42e-04	215	100	5	DOID:9970 (implicated_via_orthology)
Disease	Kuhnt-Junius degeneration (is_marker_for)	FLT1 PDGFRB	1.01e-03	14	100	2	DOID:10873 (is_marker_for)
Disease	Withdrawal Symptoms	HTR2C PER2 NOS2	1.02e-03	58	100	3	C0087169
Disease	Drug Withdrawal Symptoms	HTR2C PER2 NOS2	1.02e-03	58	100	3	C0086189
Disease	Substance Withdrawal Syndrome	HTR2C PER2 NOS2	1.02e-03	58	100	3	C0038587
Disease	Hypogonadotropic hypogonadism	CYP19A1 LEPR	1.16e-03	15	100	2	C0271623
Disease	Primary hypogonadism	CYP19A1 LEPR	1.16e-03	15	100	2	C0948896
Disease	Hypogonadism, Isolated Hypogonadotropic	CYP19A1 LEPR	1.16e-03	15	100	2	C3489396
Disease	Hypogonadism	CYP19A1 LEPR	1.32e-03	16	100	2	C0020619
Disease	carcinoma (implicated_via_orthology)	FLT1 EDA LATS1	1.35e-03	64	100	3	DOID:305 (implicated_via_orthology)
Disease	autism spectrum disorder (implicated_via_orthology)	HTR2C PDGFRB TSC1 ITPR3	1.81e-03	152	100	4	DOID:0060041 (implicated_via_orthology)
Disease	cardiomyopathy (implicated_via_orthology)	MYH2 MYH4 MYH6	1.83e-03	71	100	3	DOID:0050700 (implicated_via_orthology)
Disease	Autistic Disorder	CYP19A1 RNF8 NSD1 TSC1 NOS2	1.98e-03	261	100	5	C0004352
Disease	Mammary Carcinoma, Human	FLT1 ZNF366 CYP19A1 STMN1 LEPR SETD2 NOS2	2.09e-03	525	100	7	C4704874
Disease	Mammary Neoplasms, Human	FLT1 ZNF366 CYP19A1 STMN1 LEPR SETD2 NOS2	2.09e-03	525	100	7	C1257931
Disease	Mammary Neoplasms	FLT1 ZNF366 CYP19A1 STMN1 LEPR SETD2 NOS2	2.14e-03	527	100	7	C1458155
Disease	Metabolic Syndrome X	HTR2C INPPL1	2.29e-03	21	100	2	C0524620
Disease	complex trait	ANKRD31 DMXL2 CCDC141 LEPR ACAA2	2.33e-03	271	100	5	EFO_0010578
Disease	Breast Carcinoma	FLT1 ZNF366 CYP19A1 STMN1 LEPR SETD2 NOS2	2.40e-03	538	100	7	C0678222
Disease	neutrophil count	ZNF366 NSD1 NHLRC2 TEAD1 IFI16 LEPR ITPR2 SETD2 CEPT1 AKAP11 PLCB4 OSCP1	2.48e-03	1382	100	12	EFO_0004833
Disease	hypothyroidism (biomarker_via_orthology)	MYH6 CYP19A1 NOS2	2.57e-03	80	100	3	DOID:1459 (biomarker_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH2 MYH4 MYH6	2.57e-03	80	100	3	DOID:12930 (implicated_via_orthology)
Disease	unipolar depression, neuroticism measurement	ZNF366 KIAA1217	2.99e-03	24	100	2	EFO_0003761, EFO_0007660

Protein segments in the cluster

Peptide	Gene	Start	Entry
MMTDLKQSHSVRLND	AKR1C8	1	Q5T2L2
DLDILHNSSQMKSMS	CENPQ	241	Q7L2Z9
AHMEKELQKMTSIAN	BICD1	481	Q96G01
LRHQDSMSKSEMQVK	CCDC7	756	Q96M83
MAVSMEKKLHNATNY	HTR2C	76	P28335
KVHMNDNSTKSLMVD	APBB1IP	181	Q7Z5R6
MATFRNNHMKTKASV	AKAP11	1	Q9UKA4
IDQMKQNITMKDHLS	ECT2L	751	Q008S8
SSRIKQFHMKSPQME	ERVV-2	486	B6SEH9
TQDACAKMRKSTEHM	ANKS1A	961	Q92625
IHKESDMIMAFSVNK	DMXL2	2656	Q8TDJ6
LNDEHKTMASRAKVM	RAD54L2	376	Q9Y4B4
MAQKKMNSENSHSHE	ANKRD26	891	Q9UPS8
GSIAKMLQHAASNKM	IQGAP1	1226	P46940
APLTHKMNKMVTSEQ	ERVK-21	21	P61571
DMHDSKTKEQRLMTA	NSD1	916	Q96L73
NENMAAKKKSVAMHT	GNB5	181	O14775
KNDEKMNEVMNLAHT	ITPR2	1226	Q14571
TEIQKSFHNLMMSDK	ITPR3	1766	Q14573
MNQTDTHIVEKMAKN	ANKRD31	1046	Q8N7Z5
KKHSADVMSEMAQIA	ANKFY1	336	Q9P2R3
SKALSSMHAKNVFTM	NOS2	721	P35228
TAMLSEHTSKLKMAE	MDN1	581	Q9NU22
DAAKAEHNMSKMSTE	LATS1	46	O95835
MEQNHSETMFKKAKT	IBTK	966	Q9P2D0
ASSMDTQMHSPKKQE	CFAP65	121	Q6ZU64
HEKTMFKDLMNMQSS	DOP1B	2001	Q9Y3R5
MMVRSSHQLSKQISD	KIAA1109	2911	Q2LD37
NNHKAKMNTGMEESE	PER2	1111	O15055
TSAHLERMKKNMEQT	MYH2	1781	Q9UKX2
MSCHFQQVKTMKTAL	PDE1B	336	Q01064
EMNKAATSHFNIRVM	GALK2	231	Q01415
TMKDGLHKMQSEHVS	HHLA2	226	Q9UM44
LQADSHIKMQMSEKK	HERC6	636	Q8IVU3
QKMHKEATSDMLQDT	ABCC11	731	Q96J66
MNHMSASLKISNSSK	OR56B1	1	Q8NGI3
QTCSTQTHKIMENKM	LEPR	1146	P48357
SMENKMSFIVHTKQA	KRIT1	701	O00522
SKKTANDMIHAENMR	MSN	536	P26038
TKENLMKMQSIAESH	TUBGCP5	621	Q96RT8
AVAAMSKDKANMQHR	HNRNPH1	341	P31943
DMQRSMLSKDNTVHD	GOLGA3	521	Q08378
MEKHNLESTMKTYVS	DZIP3	836	Q86Y13
TNNHQIKVMDLETKM	NHLRC2	551	Q8NBF2
SEEDKIKAMMSQSGH	RBBP6	126	Q7Z6E9
LSKNHMLSMAKCATQ	OR5AC1	86	P0C628
KTLDQVTDMMVANSH	PARD6A	226	Q9NPB6
AVKMVHADISINMSK	EDA	361	Q92838
TNKLVVAHMTKSEMH	CEPT1	331	Q9Y6K0
LKEKSNMTRNMHATV	IFT57	406	Q9NWB7
TSHELEAAAKTMMEK	CCDC141	511	Q6ZP82
IISKSSSMFHIMKHN	CYP19A1	96	P11511
LEKTQALQKTMHEQM	GAB4	546	Q2WGN9
SHMNKLKSAIEQAMK	FNIP1	361	Q8TF40
MTKTQSIYDDMKNHR	SLC1A2	516	P43004
TNMMTHLSKINGDIA	CCDC40	661	Q4G0X9
LLLKNSDKNVHSMSM	CCDC73	721	Q6ZRK6
SDKNVHSMSMLVKPN	CCDC73	726	Q6ZRK6
SKLMSEMHSFIQIQK	PYHIN1	386	Q6K0P9
APLTHKMNKMVTSEQ	ERVK-21	21	P61565
KKNQMSKLISEMHSF	IFI16	371	Q16666
KAAEMHKMKSTTQAN	GTF2I	86	P78347
HKMKSTTQANRMSVD	GTF2I	91	P78347
SSKEHMQPFKENMEQ	FMN2	1601	Q9NZ56
AHMMMKLAQDSSQIE	RYR1	3996	P21817
DLSMFSQNMTHIIKD	COL6A6	191	A6NMZ7
GLSHSQATMKVAVKM	PDGFRB	621	P09619
MKDSSCMKVHQDSAR	MROH5	36	Q6ZUA9
SQLTEKDSMIENMKS	USO1	751	O60763
TTIKCYSTQMKMEHE	ARHGAP11A	686	Q6P4F7
KTHMVVANTMEDFQK	EPRS1	1421	P07814
DKVNSMSIEEMATKN	TMC3	416	Q7Z5M5
MRAHQAKISMENSKA	PLCB4	1076	Q15147
KMQAQKEEVLSHMND	RNF8	381	O76064
EKHASQMISNKDEMG	SNX25	406	Q9H3E2
EKMMKTTANRNHTDS	KIAA1217	596	Q5T5P2
MKNKHSKQDEPDMIS	INPPL1	411	O15357
QEKAMKLHNASNSEM	SLC35B3	246	Q9H1N7
MAVAHALTEKSKAMT	CCT3	416	P49368
EQDTSAHLERMKKNM	MYH4	1776	Q9Y623
DTSAHLERMKKNMEQ	MYH6	1776	P13533
HASIMKLNQASMDKL	OSCP1	86	Q8WVF1
SVKQQNTMKYMTALH	PLK4	536	O00444
NNFSKMAEEKLTHKM	STMN1	91	P16949
KTHMENSMVELSKLQ	ANKRD20A12P	206	Q8NF67
RSSSDHEATAMMKAQ	ATAD1	201	Q8NBU5
MAMTAENLAVKHKIS	ACAA2	161	P42765
LQNKHSDTTKEVEMM	TSC1	866	Q92574
IMSKSFMVHQKLHTQ	ZNF197	716	O14709
FSVSTSLKKHMRMHN	ZNF791	561	Q3KP31
IKTMNKVASHINEMQ	TIAM1	1221	Q13009
MFKKMSNSEIIQHLT	STAG3	151	Q9UJ98
NKKLESLLQSMEMAH	SYBU	366	Q9NX95
MCQQSMQKSSLEFHK	XAF1	61	Q6GPH4
DSNSHSLKKDPMMCQ	TEX13C	436	A0A0J9YWL9
VMKISSNSFMNVHLE	SETD2	816	Q9BYW2
ASMETIQKSKMNAEA	MYH16	396	Q9H6N6
IHALTSENTNLKKMM	UACA	841	Q9BZF9
AEHEAKMSSLSQSMR	UACA	926	Q9BZF9
KTTAVEYNKVHMAMT	ZNF658	281	Q5TYW1
KDNMKILTFDHNSMI	ZNF226	231	Q9NYT6
KAFTQTSHLKRHMMQ	ZNF366	316	Q8N895
SSSLMKNVAHMTKDH	ZNF622	261	Q969S3
HSFDSQEALMVKMTK	VSTM4	66	Q8IW00
MKHLRTQMKTHDAES	ZNF407	461	Q9C0G0
DQTAKDKALQHMAAM	TEAD1	111	P28347
NNRTMHYSISKQKMA	FLT1	596	P17948
KMTAADVSRHMNTLQ	ZFYVE26	2321	Q68DK2
MFVKNLAKSSEHSMV	TERB1	61	Q8NA31
LDSSHKQAMMEKVRS	TPCN2	371	Q8NHX9
KLVHSMQVAKMQSDR	NEB	2086	P20929
LTDSMDMVLAKQNAH	NEB	2216	P20929